The Damages (Asbestos-related Conditions) (Scotland) Act 2009 Explained
In October 2007, the House of Lords delivered a judgment that sent shockwaves through the asbestos litigation community across the United Kingdom. In Rothwell v Chemical and Insulating Co Ltd — a case that came before the Lords under the consolidated name Johnston v NEI International Combustion Ltd — the court held that pleural plaques, areas of scarring on the lining of the lung caused by asbestos exposure, did not constitute actionable damage for the purposes of a personal injury claim. Because they caused no symptoms, no disability, and no measurable impairment of lung function in themselves, they could not be said to constitute harm sufficient to found a cause of action in negligence. Thousands of claims by former asbestos workers and their families, many of whom had waited years for recognition of the harm done to them by their employers' negligent exposure to asbestos, were extinguished at a stroke.
The decision applied across England and Wales. In Scotland, the position was initially the same — the House of Lords was at that time the final court of appeal for Scotland as well as for England and Wales, and its ruling on the law of negligence applied throughout Great Britain. The effect on Scottish claimants — many of whom had worked in the shipyards, construction sites, and industrial premises that had made Scotland one of the most heavily asbestos-exposed countries in the world — was immediate and devastating.
The Scottish Parliament's response was swift, deliberate, and constitutionally significant. Within two years of the House of Lords decision, Scotland had its own legislation reversing the effect of that judgment for Scottish claimants. The Damages (Asbestos-related Conditions) (Scotland) Act 2009 received Royal Assent on the 17th of April 2009 and came into force on the 17th of June 2009. It is one of the most important pieces of legislation ever passed by the Scottish Parliament in the field of personal injury law, and it represents a clear and meaningful example of the Scottish legal system charting its own course on a matter of fundamental importance to the health and wellbeing of Scottish workers and their families.
This essay explains the Act in full — its background, its provisions, its constitutional journey through the courts, its practical significance, and its legacy for asbestos-related disease claims in Scotland today.
The Background: Pleural Plaques and the Rothwell Decision
To understand the significance of the 2009 Act, it is necessary to understand what pleural plaques are and why the Rothwell decision was so controversial.
The pleura is the thin membrane that lines the lungs and the chest cavity. When asbestos fibres are inhaled and become lodged in the lung tissue, the body responds over time with a process of inflammation and scarring. In some cases this scarring takes the form of discrete, localised patches on the pleural surface — areas of calcified fibrous tissue that are visible on chest X-ray and CT scan. These patches are known as pleural plaques.
Pleural plaques are caused by asbestos exposure. Their presence on a chest X-ray or CT scan is a reliable marker of significant past exposure — they do not occur in the absence of asbestos inhalation, and their identification therefore confirms that the person who has them was exposed to asbestos at some point in their life. They are, in that sense, physical evidence written on the body of a worker's exposure to a substance their employer failed to adequately protect them from.
What pleural plaques do not do — in themselves and without more — is cause symptoms or impair lung function. A person with pleural plaques may have no breathlessness, no chest pain, and no measurable reduction in their ability to breathe. In that narrow clinical sense, pleural plaques do not make the person ill in any immediately observable way.
What pleural plaques do represent, however, is something profoundly significant to the people who have them. They are evidence of substantial asbestos exposure. They are a marker of increased risk — people with pleural plaques have a higher risk than the general population of developing more serious asbestos-related conditions, including mesothelioma, asbestosis, and asbestos-related lung cancer. They cause genuine anxiety — the knowledge that one's lungs bear the physical evidence of asbestos exposure, and that this exposure carries elevated risks of serious and potentially fatal disease, is a source of real and understandable distress. And they represent a physical change to the body caused by another's negligence that the affected person carries for the rest of their life.
Before the Rothwell decision, the courts in Scotland and England had treated pleural plaques as actionable damage — as harm sufficient to found a personal injury claim. Claimants with pleural plaques could recover compensation reflecting the physical change to their lungs, the associated anxiety about future disease, and the increased risk they faced. Thousands of former asbestos workers had pursued and settled such claims over the years.
The House of Lords in Rothwell took a different view. Because pleural plaques caused no symptoms and no functional impairment, they could not constitute damage in the legal sense — they were a physical change without adverse physical consequences, and the law of negligence required actual harm, not merely the risk of harm or the anxiety caused by the awareness of risk. The anxiety itself, the court held, was not a recognised psychiatric illness and therefore could not found a separate claim.
The Scottish Parliament's Response
The Rothwell decision was met with widespread condemnation in Scotland, particularly among trade unions, former industrial workers, and the solicitors who had spent years representing asbestos-exposed workers in the courts. The argument that a physical change to the lungs caused by an employer's negligent exposure to asbestos did not constitute harm — that a worker could carry the permanent physical evidence of their employer's breach of duty on their own body without being entitled to any recognition or compensation — was regarded by many as fundamentally unjust.
The Scottish Parliament moved quickly. A consultation was launched in 2008, gathering evidence from medical experts, legal practitioners, trade unions, employers' representatives, and insurers. The responses confirmed that the impact of the Rothwell decision on Scottish workers and their families was serious, that the arguments for legislative reversal were strong, and that the Scottish Parliament had both the constitutional competence and the moral case for action.
The Damages (Asbestos-related Conditions) (Scotland) Act 2009 was introduced to the Scottish Parliament and passed with broad cross-party support. Its passage was not without controversy — the insurance industry argued strongly against it, contending that it would impose significant financial liabilities on insurers for conditions that caused no physical harm, and that it was constitutionally questionable. But the Parliament's view prevailed, and the Act received Royal Assent in April 2009.
The Act is deliberately short and direct. It does not attempt a comprehensive restatement of the law on asbestos-related conditions. It does one specific thing: it reverses the effect of Rothwell for Scotland, by providing that pleural plaques and other specified asbestos-related conditions do constitute personal injury for the purposes of an action of damages in Scotland.
The Provisions of the Act
The Damages (Asbestos-related Conditions) (Scotland) Act 2009 contains four operative sections and is one of the most concise and directly expressed pieces of legislation on the Scottish statute book.
Section 1 is the heart of the Act. It provides that asbestos-related pleural plaques constitute personal injury which is not negligible. This provision directly and explicitly reverses the Rothwell holding for Scotland. A person with pleural plaques caused by negligent asbestos exposure has, by virtue of this section, suffered personal injury for the purposes of bringing an action of damages against the person responsible for that exposure. The injury is not to be regarded as negligible — the Act forecloses the argument that the physical change is too minor or too inconsequential to found a claim.
The significance of the words not negligible cannot be overstated. The Rothwell decision had in effect treated pleural plaques as negligible — as below the threshold of harm that the law of negligence recognises. Section 1 of the 2009 Act removes that characterisation for Scotland. Whatever the position in England and Wales, in Scotland pleural plaques are personal injury that is not negligible.
Section 2 extends the principle beyond pleural plaques to other asbestos-related conditions. It provides that asymptomatic pleural thickening and asymptomatic asbestosis — conditions that, like pleural plaques, may be present without causing symptoms at the time of diagnosis — also constitute personal injury which is not negligible for the purposes of an action of damages. This provision ensures that the reversal of Rothwell is not limited to the specific condition of pleural plaques but extends to the full range of asymptomatic asbestos-related conditions that might otherwise have been affected by the same reasoning.
Section 3 addresses the interaction between a claim for an asymptomatic condition under sections 1 or 2 and any subsequent claim for a more serious asbestos-related condition. It provides that the bringing of an action for pleural plaques or other asymptomatic conditions does not bar a subsequent action for a different asbestos-related condition that develops later. This provision is critical to the practical utility of the Act — it means that a claimant who recovers compensation for pleural plaques under the Act does not thereby exhaust their right to claim for mesothelioma, asbestosis, or other serious conditions if they develop in the future. The two claims are treated as claims for separate and distinct conditions rather than as part of a single continuing cause of action.
Section 4 deals with the temporal application of the Act. It provides that the Act applies to actions commenced on or after the date the Act came into force, and — crucially — to actions that had been commenced before that date but had been sisted or stayed pending the outcome of the Rothwell litigation. This provision ensured that claimants whose cases had been held up while the Rothwell litigation ran its course were able to revive their claims under the new Act without being told that the limitation period had expired during the period of delay.
The Constitutional Challenge
The passage of the 2009 Act did not end the controversy. The insurance industry mounted a legal challenge to the Act's validity, arguing that the Scottish Parliament had exceeded its legislative competence in passing it. Under the Scotland Act 1998, the Scottish Parliament can legislate on devolved matters but cannot legislate in a way that is incompatible with the European Convention on Human Rights or that falls outside its devolved competence.
The insurers' challenge was brought on the basis that the Act violated their rights under Article 1 of Protocol 1 to the European Convention on Human Rights — the right to peaceful enjoyment of possessions. The argument was that the Rothwell decision had settled the law on pleural plaques, creating a legitimate expectation that insurers would not be liable for these conditions, and that the 2009 Act retrospectively imposed liability in a way that interfered with the insurers' property rights.
The challenge reached the UK Supreme Court in AXA General Insurance Ltd v Lord Advocate, decided in 2011. The Supreme Court rejected the insurers' challenge and upheld the validity of the 2009 Act in its entirety. The judgment is one of the most significant constitutional decisions in the history of the Scottish Parliament, and it has implications that extend far beyond the specific context of asbestos litigation.
The Supreme Court held that the Scottish Parliament is a democratically elected legislature with a broad mandate to pass legislation in the public interest within its devolved competence. The court emphasised that the Parliament's exercise of its legislative powers should be accorded a high degree of respect, and that courts should be slow to interfere with legislation passed by a democratic legislature on social and economic matters unless there is a clear and compelling reason to do so.
On the specific question of the insurers' Article 1 Protocol 1 rights, the court held that any interference with the insurers' property rights was justified as being in the general interest. The Parliament had made a considered judgment, following consultation, that the Rothwell decision produced an unjust outcome for Scottish workers exposed to asbestos through their employers' negligence, and that legislative correction was appropriate. That judgment was a legitimate exercise of the Parliament's democratic mandate, and the insurance industry's commercial interests could not prevail over it.
The AXA decision is therefore significant on two levels. At the level of asbestos litigation, it confirmed that the 2009 Act is valid and enforceable, that pleural plaques are actionable personal injury in Scotland, and that the insurance industry's attempt to escape liability through constitutional challenge had failed. At the constitutional level, it established important principles about the relationship between the Scottish Parliament, the courts, and the European Convention on Human Rights that have informed Scottish constitutional jurisprudence ever since.
What the Act Means for Claimants
For former asbestos workers and their families in Scotland, the practical significance of the 2009 Act is considerable. It means that a worker who was negligently exposed to asbestos by their employer and who has developed pleural plaques as a result of that exposure has a valid and enforceable personal injury claim in Scotland, regardless of the position in England and Wales.
The compensation available for pleural plaques under the Act reflects the physical change to the lungs, the anxiety reasonably associated with the diagnosis, and the awareness of elevated risk of future serious disease. The awards are not at the level of compensation for symptomatic conditions — pleural plaques that cause no symptoms attract lower compensation than conditions causing breathlessness, disability, or pain — but they represent meaningful recognition of the harm done and the wrong suffered.
The interaction between a pleural plaques claim under the Act and any future claim for a more serious condition is managed by section 3 of the Act, as explained above. A claimant who settles a pleural plaques claim does not thereby foreclose a future mesothelioma claim if that terrible disease develops. The two claims are for separate and distinct conditions, and the settlement of the first does not bar the second. This is of enormous practical importance — it means that a claimant can obtain some recognition and financial redress now, while preserving their right to full compensation if the worst happens later.
For asymptomatic pleural thickening and asymptomatic asbestosis — the other conditions covered by section 2 of the Act — the same principles apply. These conditions are actionable personal injury in Scotland regardless of whether they are currently causing symptoms. Their diagnosis, caused by negligent asbestos exposure, gives rise to a claim that can be pursued against the responsible employer or their insurer.
The Limitation Position
The three year limitation period under the Prescription and Limitation (Scotland) Act 1973 applies to claims under the 2009 Act in the same way as to other personal injury claims. The date of knowledge provisions apply — the clock runs from the date the claimant knew or ought to have known that they had suffered a significant injury and that it was attributable to asbestos exposure.
In pleural plaques cases, the date of knowledge is typically the date on which the claimant was informed of the diagnosis — either by their own GP or specialist, or following a chest X-ray or CT scan carried out for another purpose that incidentally revealed the plaques. Where the claimant was aware of their asbestos exposure history and received a diagnosis of pleural plaques, the date of knowledge is clear. Where the diagnosis was made but the significance of it in terms of the legal rights it gave rise to was not immediately apparent, the date of knowledge question requires more careful analysis.
Section 4 of the Act, as noted above, makes specific provision for claimants whose cases were sisted or delayed pending the Rothwell litigation. For new claimants diagnosed with pleural plaques after the Act came into force, the standard three year limitation period applies from the date of knowledge of the diagnosis.
The Position in England and Wales
It is important to emphasise the continuing divergence between Scotland and England on the pleural plaques question. The Damages (Asbestos-related Conditions) (Scotland) Act 2009 applies only in Scotland. In England and Wales, the Rothwell decision remains the law. A former asbestos worker in England diagnosed with pleural plaques has no right to compensation for that diagnosis, because in England pleural plaques do not constitute actionable damage. The same worker in Scotland, with the same diagnosis and the same exposure history, has a valid claim under the 2009 Act.
This divergence is one of the most striking examples in the personal injury field of the real and meaningful differences between Scots law and English law — differences that are not merely procedural or technical but that determine whether a person has any legal rights at all in respect of harm done to their body. It is a difference that has direct and immediate financial consequences for affected workers and their families, and it is one that makes very clear why Scottish workers need Scottish legal advice rather than generic UK-wide guidance.
The insurance industry has periodically sought legislative change in England to introduce equivalent provision to the Scottish Act, and there have been Parliamentary discussions about the issue, but as of the time of writing no equivalent legislation has been enacted in England and Wales. The divergence therefore persists.
Asbestosis and Pleural Thickening: The Symptomatic Cases
While the 2009 Act is primarily associated with pleural plaques and the reversal of Rothwell, its extension in section 2 to asymptomatic pleural thickening and asymptomatic asbestosis is also significant. These conditions, like pleural plaques, may be present on imaging before they cause any symptoms. The Act provides that their asymptomatic presence is actionable personal injury in Scotland.
Where these conditions have progressed to the point of causing symptoms — breathlessness, reduced exercise tolerance, chest tightness — they are more serious and more substantially compensable conditions in their own right, regardless of the 2009 Act. The Act's significance for these conditions is specifically in relation to the asymptomatic phase — the period between diagnosis on imaging and the development of symptoms — during which the 2009 Act ensures that the affected person is not left without any right to compensation.
Symptomatic asbestosis is a serious and progressive condition that causes significant disability. It restricts breathing, reduces exercise tolerance, and in severe cases is life-limiting. Compensation for symptomatic asbestosis reflects the severity of the breathlessness, the disability caused, the treatment required, and the impact on the claimant's quality of life and life expectancy. These are substantial claims that do not depend on the 2009 Act — they are founded on the serious symptomatic harm caused by the condition itself.
Diffuse pleural thickening — where the scarring of the pleura is widespread rather than localised — is similarly a more serious condition than discrete pleural plaques. Where it causes breathlessness and reduced lung function, it is compensable on the basis of those symptoms regardless of the 2009 Act. The Act's contribution is again in relation to the asymptomatic cases that Rothwell would otherwise have excluded.
The Legacy of the Act
The Damages (Asbestos-related Conditions) (Scotland) Act 2009 has a legacy that extends beyond its immediate practical provisions. It is a demonstration of the Scottish Parliament's willingness and ability to use its legislative powers to correct what it regarded as an unjust legal outcome, to protect the interests of Scottish workers against the consequences of a judicial decision that prioritised technical legal reasoning over human justice, and to ensure that the distinctive values of Scots law — including its approach to the recognition of harm and the vindication of rights — are reflected in the law that applies in Scotland.
The constitutional validation of the Act by the UK Supreme Court in AXA confirmed that the Parliament has the democratic legitimacy and the legal competence to make these kinds of choices, and that judicial review of democratically enacted legislation in Scotland is appropriately restrained. This has implications not just for asbestos litigation but for the broader relationship between the Scottish Parliament, the courts, and the law of Scotland.
For the asbestos-affected communities of Scotland — the former shipyard workers of the Clyde, the construction workers, the factory workers, the teachers in asbestos-containing schools, and their families — the Act provides a recognition that their physical experience of asbestos exposure, permanently written on their lungs in the form of pleural plaques, is not to be dismissed as legally insignificant. It is personal injury. It is not negligible. And it gives rise to rights that Scottish law recognises and enforces.
The Bottom Line
The Damages (Asbestos-related Conditions) (Scotland) Act 2009 is a short statute with profound significance. It reversed the effect of a House of Lords decision that had denied compensation to thousands of Scottish workers for a physical condition caused by their employers' negligence. It established that pleural plaques, asymptomatic pleural thickening, and asymptomatic asbestosis are personal injury in Scotland. It survived a major constitutional challenge before the UK Supreme Court. And it created a lasting divergence between Scots law and English law on the rights of asbestos-exposed workers that continues to this day.
For anyone in Scotland who has been diagnosed with an asbestos-related condition — whether symptomatic or asymptomatic, whether a worker directly exposed or a family member exposed secondarily — the 2009 Act is part of the legal landscape that defines their rights. Understanding what it provides, what it reversed, and how it interacts with the broader framework of asbestos disease litigation in Scotland is essential context for anyone seeking to understand those rights and to enforce them.